Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong · Delayed Price · Currency is HKD 1.150
-0.050 (-4.17%)
May 12, 2026, 4:08 PM HKT
HKG:0460 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 179.7 | -216.66 | -54.02 | -1,915 | 416.51 |
Depreciation & Amortization | 189.08 | 228.34 | 211.88 | 338.77 | 278.97 |
Other Amortization | 36.21 | 30.09 | 14.35 | 31.03 | 30.4 |
Loss (Gain) From Sale of Assets | -17.19 | -5.22 | -7.38 | -200.07 | -56.82 |
Asset Writedown & Restructuring Costs | - | - | - | 1,338 | 131.3 |
Loss (Gain) From Sale of Investments | -31.43 | -27.11 | -153.02 | 279.36 | -8.44 |
Loss (Gain) on Equity Investments | -11.61 | 15.23 | 53.62 | 80.88 | 158.58 |
Stock-Based Compensation | 9.03 | 418.02 | 89.08 | 89.67 | 59.35 |
Provision & Write-off of Bad Debts | 51.95 | 6.35 | -7.95 | 28.44 | 36.51 |
Other Operating Activities | 150.21 | -191.62 | -58.19 | -206.31 | -124.57 |
Change in Accounts Receivable | -690.78 | -268.55 | 265.79 | -163.68 | -245.24 |
Change in Inventory | -195.48 | 130.78 | 37.74 | -60.44 | -226.81 |
Change in Accounts Payable | 315.99 | 28.49 | -198.81 | 415.54 | 195.75 |
Change in Unearned Revenue | -9.24 | 128.01 | 6.38 | -46.03 | 29.77 |
Operating Cash Flow | -23.56 | 276.14 | 199.49 | 46.49 | 665.29 |
Operating Cash Flow Growth | - | 38.43% | 329.07% | -93.01% | 192.91% |
Capital Expenditures | -58.35 | -70.71 | -125.35 | -402.46 | -601.02 |
Sale of Property, Plant & Equipment | 1.7 | 3.71 | 15.54 | 14.35 | 3.13 |
Cash Acquisitions | 6.19 | - | - | - | -153.38 |
Divestitures | 13.8 | - | 14.93 | 88.45 | - |
Sale (Purchase) of Intangibles | -136.15 | -109.07 | -170.04 | -187.49 | -124.57 |
Sale (Purchase) of Real Estate | 39.6 | 15.77 | -1.3 | - | - |
Investment in Securities | -380.22 | 562.17 | 246.63 | -1,190 | 151.15 |
Other Investing Activities | 155.75 | 285.65 | 224.65 | 38.22 | 376.39 |
Investing Cash Flow | -296.48 | 758.24 | 169.88 | -1,661 | -337.57 |
Long-Term Debt Issued | 272.41 | 318.25 | 385.59 | 480.32 | 836.08 |
Long-Term Debt Repaid | -279.94 | -649.98 | -416.97 | -328.05 | -545.63 |
Net Debt Issued (Repaid) | -7.53 | -331.73 | -31.38 | 152.27 | 290.46 |
Issuance of Common Stock | - | - | - | - | 2.74 |
Repurchase of Common Stock | -188.63 | -20.3 | -33.81 | - | -206.41 |
Common Dividends Paid | -90.89 | -177.08 | -298.56 | -130.62 | -122.89 |
Other Financing Activities | 645.2 | -761.55 | -55.81 | 924.32 | 786.76 |
Financing Cash Flow | 358.16 | -1,291 | -419.56 | -238.93 | 750.66 |
Net Cash Flow | 38.12 | -256.28 | -50.2 | -1,854 | 1,078 |
Free Cash Flow | -81.91 | 205.44 | 74.14 | -355.97 | 64.28 |
Free Cash Flow Growth | - | 177.09% | - | - | - |
Free Cash Flow Margin | -3.13% | 10.81% | 3.98% | -16.32% | 2.11% |
Free Cash Flow Per Share | -0.01 | 0.02 | 0.01 | -0.04 | 0.01 |
Cash Interest Paid | 48.16 | 43.46 | 53.98 | 55.68 | 27.93 |
Cash Income Tax Paid | 184.55 | 88.92 | 83.8 | 156.98 | 203.53 |
Levered Free Cash Flow | -197.19 | -838.63 | 1,458 | -532.22 | -242.96 |
Unlevered Free Cash Flow | -71.2 | -666.79 | 1,626 | -400.23 | -169.61 |
Change in Working Capital | -579.5 | 18.74 | 111.1 | 145.4 | -246.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.